Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Phakic Intraocular Lenses (IOL) Market Snapshot (2023 to 2033)

The anticipated size of the phakic intraocular lenses (PIOL) market in 2022 was US$ 377.1 million and is estimated to be US$ 412.9 million in 2023.

The surge in number of people who are myopic have found to be risen in recent years, as this refractive correction option has become increasingly significant. According to Future Market Insights, the phakic intraocular lenses (IOL) market is anticipated to expand at a CAGR of 8.1% between 2023 and 2033, totaling around US$ 897.4 million by 2033.

The global phakic intraocular lenses (PIOL) market reached US$ 344.4 million in 2021. Sales are projected to expand at a 9.5% CAGR over the assessment period, with the market valuation reaching US$ 819.5 million by 2032. Posterior chamber phakic IOL is leading the market. The segment accounted for about 68.0% of the total market share in 2021, and the trend is expected to continue over the forecast period.

Phakic intraocular lenses (PIOLs) are clear implantable lenses that are surgically inserted in the anterior chamber or the posterior chamber of the eye without removing the natural lens, allowing light to focus on the retina for better-uncorrected vision.

Phakic intraocular lenses have a high optical quality and might potentially improve visual acuity in myopic patients due to retinal magnification. PIOL implantation appeals to both patients and refractive surgeons since it is a reversible refractive technique that preserves accommodative function. Further, corneal thickness poses little bearing on correction, and hence, PIOLs offer fast visual recovery times, and steady refraction after implantation.

Attribute Details
Projected Forecast Value (2022) US$ 377.1 million
Projected Forecast Value (2023) US$ 412.9 million
Projected Forecast Value (2033) US$ 897.4 million
Growth rate 8.1% CAGR
Forecast period 2023 to 2033

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Phakic Intraocular Lenses Market Historic Historical Analysis (2018 to 2022) Vs. Forecast Outlook (2023 to 2033)

The global phakic intraocular lenses market expanded at a CAGR of 10.3% between 2018 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 8.1% between 2023 and 2033.

The phakic intraocular lenses market represented around 7.0% of the overall US$ 4.9 billion global intraocular lenses market in 2021.

Phakic intraocular lenses are a popular surgical option for correcting myopia. Anterior chamber iris-fixated, anterior chamber angle-supported, and posterior chamber phakic intraocular lenses are the three types of lenses available. Although phakic intraocular lenses have high efficacy, they have undergone numerous improvements over the years to improve their safety profile and reduce lens-related problems such as cataract formation, endothelial cell death, and corneal decompensation.

For long-term management of stable myopia, lens surgery for refractive purposes (refractive lens exchange [RLE]), laser refractive surgery, and phakic intraocular lens (pIOL) implantation are available currently. Further, refractive surgery with pIOL implantation is a reversible technique, whereas laser refractive surgery and refractive lens exchange are permanent procedures.

Phakic IOL surgery has been proven to enhance vision, promote patient satisfaction, and reduce the risk of corneal ectasia. Phakic IOLs outperform LASIK and photorefractive keratectomy in terms of best spectacle-corrected visual acuity (BSCVA), refractive predictability and stability, and patient satisfaction. Complications of corneal ectasia associated with excimer laser surgery and refractive lens exchange are eliminated through the use of PIOLS. The phakic intraocular lenses (IOL) market is being driven by factors such as:

  • The growing elderly population and age-related eye disorders.
  • Rising initiatives by the government to manage and treat blindness instigated by cataracts.
  • High prevalence of ocular diseases and diabetes globally.
  • Technological advancements in intraocular lens design and implantation.

What are the Key Opportunities for the Phakic Intraocular Lenses (IOL) Manufacturers?

Revolutionization of Refractive Surgery in the Case of Phakic Intraocular Lenses

Phakic intraocular lenses have revolutionized refractive surgery and continue to be a great alternative for individuals who are not ideal candidates for laser vision correction. Since no ultrasonic energy is communicated to the ocular tissues, visual recovery is swift and intraocular inflammation is limited with phakic IOL implantation compared to cataract extraction with phacoemulsification.

There is no regression impact with phakic IOLs, unlike excimer laser operations, because corneal healing is not required. For patients with residual spherical or astigmatic refractive error after phakic IOL implantation, an excimer laser enhancement approach may be required.

For stable keratoconus, PIOL implantation is a viable refractive surgical approach. After cataract surgery, PIOL has also been demonstrated to be a useful and reliable choice for improving postoperative refractive performance and lowering spectacle dependence.

Presbyopia treatment with a multifocal implantable phakic refractive IOL, such as the presbyopia implantable phakic contact lens (PIOL), is a recent breakthrough. This novel PC-PIOL is meant to correct presbyopia, myopia, hyperopia, and astigmatism in those aged 40 to 55 who do not have cataracts. With good unassisted eyesight, the PC-PIOL has the distinction of being reversible.

Owing to these advancements within the field of intraocular lenses and technological advancements in the ocular manifestation of vision correction, the global market for phakic intraocular lenses is set to gain traction over the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors are Restraining the Demand for Phakic Intraocular Lenses?

Lack of Reimbursements for Implantation Procedures

Lack of reimbursements for implantation procedures has proven to be a key roadblock to the overall phakic intraocular lens market. While secondary implant procedures are sometimes covered by Medicare, surgeries conducted primarily for refractive purposes are not.

For patients with presbyopia and high hyperopia, alternative treatments such as refractive lens exchange may be a superior preference to phakic IOL refractive surgery. Because of the high costs of phakic intraocular lenses and their implantation procedures, as well as the lack of standardized reimbursement schemes, the market faces a challenge in terms of patient uptake.

While lens replacement surgery is technically not approved by the FDA, some eye doctors will conduct it off-label in specific circumstances. This is legal and is sometimes the most effective method to rectify distinct vision abnormalities. These factors are expected to limit sales in the market over the forecast period.

Region-wise Insights

What is Driving North America’s Phakic Intraocular Lenses Market?

Rising Preference for Phakic Lens Implant Surgery is Estimated to Augment Growth

The United States of America dominated North America’s phakic intraocular lenses market, accounting for about 24.3% of the total market share whereas North America holds a value share of 28.7%. Rising awareness regarding personalized medicine as well as targeted disease therapy is expected to boost the market in the forthcoming years.

With high technological demand arising from growing awareness, as well as large volumes of ophthalmic patients using spectacles for corrective vision enhancement, the adoption of phakic intraocular lenses within the country is set to increase over the forecast period.

What is Asia Pacific’s Phakic Intraocular Lenses Market Outlook?

Growing Popularity of Phakic Implants Will Spur Demand

Sales in China are expected to increase at an 11.80% CAGR over the forecast period. According to the IAPB's Word Report on Vision issued in 2019, the cataract patient population between the age group of 45 to 89 years is expected to reach 132 million by 2020. This also means that intraocular lenses are in high demand in China.

The cataract surgery market has expanded from 2.4 billion Yuan in 2005 to 25.5 Billion Yuan in 2018, which is higher than a tenfold increase, thanks to notable development in cataract surgeries and high per-client transactions.

International brands have long monopolized the intraocular lens market in India expanding at a CAGR of 11%, particularly the high-end ones, putting patients at a financial disadvantage due to the exorbitant prices of imported devices.

What Makes the Europe Phakic Intraocular Lenses Market Lucrative?

Increasing Influx of Medical Tourists is Likely to Boost the Adoption of PIOL Procedure

Demand in Germany is set to increase at a value of 2.7% in Europe with a value share of 34.1% of the phakic intraocular lenses (IOL) market during the forecast period. The country has high volumes of myopic population groups, with around 50% progression of myopic maculopathy, as per a cohort study by the Gutenberg Health Study (GHS), in 2022.

Indications associated with macular degeneration and the increasing diabetic population within the country, propose a need for corrective procedural uptake considering the United Kingdom to expand at a CAGR of 9.40%. These factors are anticipated to spur demand for phakic intraocular lenses in Germany over the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative Analysis of the Phakic Intraocular Lenses Market

Phakic Intraocular Lenses Market:

Attributes Phakic Intraocular Lenses Market
CAGR (2023 to 2033) 8.1%
Market Value 2023 US$ 412.9 million
Growth Factor The key reason is that these lenses are ideally used in young adults that seek ocular prescription independence by the preservation of accommodation, thus raising the market.
Future Opportunities Advancements in excimer laser procedures are presented in the development of implantable intraocular lenses leading to effective vision corrective outcomes.
Market trends Phakic intraocular lenses are considered to have a high optical quality that might potentially help in the improvement of visual acuity in myopic patients.

Multifocal Intraocular Lens Market:

Attributes Multifocal Intraocular Lens Market
CAGR (2023 to 2033) 7.9%
Market Value 2023 US$ 599.5 million
Growth Factor Due to the provisional benefits of multifocal intraocular lenses, with high precision, and improvement of visualization, the multifocal intraocular lens segment is dominated.
Future Opportunities The main focus of companies is on the rise of emerging markets, leading to a gradual shift toward new technologies, which provides a significant growth opportunity for multifocal intraocular lens manufacturers.
Market trends Traditional mono-focal lenses help vision zones by allowing patients to see far, intermediate, and close distances efficiently and precisely.

Toric Intraocular Lens Market:

Attributes Toric Intraocular Lens Market
CAGR (2023 to 2033) 6.66%
Market Value 2023 US$ 492.33 million
Growth Factor Toric intraocular lenses are mainly designed for eliminating the need for incision implants, which are previously required during astigmatism surgical procedures, increasing their popularity among people.
Future Opportunities The rapid growth of the geriatric population is associated with eye disorders, with the increase in the prevalence of eye diseases and diabetes in the overall population globally.
Market trends Government initiatives taken to control and treat cataract-related blindness might mainly drive the market.

Category-wise Insights

Which Phakic Intraocular Lenses Product is Driving Sales?

Adoption of Posterior Chamber Phakic IOL to Remain High

Sales of posterior chamber phakic IOL are expected to increase at a value share of 68% during the assessment period. Posterior chamber phakic intraocular lens implantation is a procedure for implanting an intraocular lens in front of the native crystalline lens. The advantages of posterior chamber phakic IOL implantation include potential reversibility, accommodation preservation, and minimal complications.

Which Indication of Phakic Intraocular Lenses is Largely in Focus?

Demand for Phakic Intraocular Lenses for Myopia is Likely to Gain Traction

Demand in the myopia segment is anticipated to hold a market share of 36% during the forecast period. Ocular diseases have observed high variations in terms of disease prevalence, and indications like myopia have presented a high rate of prevalence worldwide. The growing need to address ocular disease progressions, along with the rising development of implantable devices will propel sales in this segment.

Which End User Benefits the Most with Sales of Phakic Intraocular Lenses?

Sales of Phakic Intraocular Lenses across Hospitals might Continue to rise

Hospitals held the high market share at 55.0%. Insertion of an intraocular lens implant is the most common eye surgery procedure. Around 6 million procedures are done annually by eye surgeons as it requires huge capital investment for surgical and theatre equipment, hospitals present a great value in terms of procedural adoption rates.

Competitive Landscape

Some of the prominent players profiled in the global market are-

  • STAAR SURGICAL
  • Care Group
  • Ophtec BV/Abbott
  • Johnson & Johnson
  • Ambu
  • Boston Scientific
  • Olympus
  • Verathon Inc
  • Duomed
  • PENTAX Medical
  • Neoscope Inc

Some of the important developments of the key players in the market are:

  • In July 2020, STAAR Surgical Company received CE Mark approval from its European Notified Body, DEKRA, for their new commercial product offering EVO Viva.
  • In December 2019, Johnson & Johnson received the USA FDA approval and launched of TECNIS Toric II 1-Piece Intraocular Lens (IOL).
  • In December 2022, Johnson & Johnson took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company. The new corporate brand comes to life through a compelling purpose and a timeless visual brand.

Report Scope

Attribute Details
Growth Rate CAGR of 8.1% from 2023 to 2033
Market value in 2023 US$ 412.9 million
Market value in 2033 US$ 897.4 million
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units US$ million for Value and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • By Product
  • By Indication
  • By End-user
  • By Region
Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Rest of Latin America
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Western Europe
  • Poland
  • Russia
  • Czech Republic
  • Romania
  • Rest of Eastern Europe
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • Rest of South Asia and the Pacific
  • China
  • Japan
  • South Korea
  • GCC Countries
  • South Africa
  • Israel
  • Rest of The Middle East and Africa
Key Companies Profiled
  • STAAR SURGICAL
  • Care Group
  • Ophtec BV/Abbott
  • Johnson & Johnson
  • Ambu
  • Boston Scientific
  • Olympus
  • Verathon Inc
  • Duomed
  • PENTAX Medical
  • Neoscope Inc
Customisation Scope Available on Request

Key Market Segments Covered in Phakic Intraocular Lenses Industry Research

By Product:

  • Posterior Chamber Phakic IOL
  • Anterior Chamber Phakic IOL

By Indication:

  • Myopia
  • Hyperopia
  • Astigmatism

By End User:

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa

Frequently Asked Questions

How Big is the Phakic Intraocular Lenses (IOL) Market?

The market is valued at US$ 412.9 million in 2023.

Who are the Key Phakic Intraocular Lenses (IOL) Market Players?

Olympus, Verathon Inc, and Duomed are the key market players.

What is the Growth Forecast for the Phakic Intraocular Lenses (IOL) Market?

The market is forecast to register a CAGR of 8.1% through 2033.

What is the Expected Market Size in 2033?

The market is expected to reach US$ 897.4 million by 2033.

What is the Market CAGR of China over the Forecast period?

Sales in China are expected to increase at an 11.80% CAGR over the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Posterior Chamber Phakic IOL

        5.3.2. Anterior Chamber Phakic IOL

    5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033

        6.3.1. Myopia

        6.3.2. Hyperopia

        6.3.3. Astigmatism

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Ophthalmology Clinics

        7.3.3. Ambulatory Surgical Centers

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Indication

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Indication

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Indication

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Indication

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product

        11.2.3. By Indication

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Indication

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product

        12.2.3. By Indication

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product

        13.2.3. By Indication

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product

        14.2.3. By Indication

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Indication

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product

            16.1.2.2. By Indication

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product

            16.2.2.2. By Indication

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product

            16.3.2.2. By Indication

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product

            16.4.2.2. By Indication

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product

            16.5.2.2. By Indication

            16.5.2.3. By End User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product

            16.6.2.2. By Indication

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product

            16.7.2.2. By Indication

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product

            16.8.2.2. By Indication

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product

            16.9.2.2. By Indication

            16.9.2.3. By End User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product

            16.10.2.2. By Indication

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product

            16.11.2.2. By Indication

            16.11.2.3. By End User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product

            16.12.2.2. By Indication

            16.12.2.3. By End User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product

            16.13.2.2. By Indication

            16.13.2.3. By End User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product

            16.14.2.2. By Indication

            16.14.2.3. By End User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product

            16.15.2.2. By Indication

            16.15.2.3. By End User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product

            16.16.2.2. By Indication

            16.16.2.3. By End User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product

            16.17.2.2. By Indication

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product

            16.18.2.2. By Indication

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product

            16.19.2.2. By Indication

            16.19.2.3. By End User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product

            16.20.2.2. By Indication

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product

            16.21.2.2. By Indication

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product

            16.22.2.2. By Indication

            16.22.2.3. By End User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product

            16.23.2.2. By Indication

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Indication

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. STAAR SURGICAL

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Care Group

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Ophtec BV/Abbott

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Johnson & Johnson

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Ambu

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Boston Scientific

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Olympus

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Verathon Inc

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Duomed

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. PENTAX Medical

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Neoscope Inc

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Diabetic Macular Edema Market

Published : May 2024

Healthcare

Refractive Surgery Device Market

Published : March 2024

Consumer Product

Therapeutic Contact Lenses Market

Published : January 2023

Healthcare

Excimer and Femtosecond Ophthalmic Lasers Market

Published : October 2022

Explore Healthcare Insights

View Reports

Phakic Intraocular Lenses (IOL) Market